DANONE SA (BSN) Stock Forecast & Price Target
BSN Analyst Ratings
BSN Stock 12 Month Forecast
Average Price Target
EUR 78.33▲(19.59% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Celine Pannuti CFA | J.P. Morgan | EUR 90 | buy | 37.40%Upside | Reiterated | 10/29/26 | ||
| Axel Herlinghaus | DZ BANK AG | ― | buy | ― | Reiterated | 10/29/26 | ||
| James Edwardes Jones | RBC Capital | EUR 78→EUR 76 | hold | 16.03%Upside | Reiterated | 10/28/26 | ||
| David Hayes | Jefferies | EUR 60 | sell | -8.40%Downside | Reiterated | 10/28/26 | ||
| Guillaume Delmas | UBS | EUR 93 | buy | 41.98%Upside | Reiterated | 10/28/26 | ||
| Callum Elliott | Bernstein | EUR 92 | buy | 40.46%Upside | Reiterated | 10/28/26 | ||
| Tom Sykes | Deutsche Bank | EUR 61→EUR 59 | hold | -9.92%Downside | Reiterated | 10/05/26 | ||
| David Roux | Morgan Stanley | EUR 80→EUR 83 | buy | 26.72%Upside | Reiterated | 07/30/26 | ||
| Warren Ackerman | Barclays | EUR 81→EUR 83 | buy | 26.72%Upside | Reiterated | 07/07/26 | ||
| Banco Santander | EUR 85 | buy | 29.77%Upside | Upgraded | 06/10/26 | |||
| Jon Cox | Kepler Capital | EUR 85 | buy | 29.77%Upside | Reiterated | 05/04/26 | ||
| Matthew Abraham | Berenberg Bank | EUR 83→EUR 79 | hold | 20.61%Upside | Reiterated | 04/23/26 | ||
| Jeff Stent | Exane BNP Paribas | EUR 83 | buy | 26.72%Upside | Upgraded | 03/04/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Celine Pannuti CFA | 10/29/26 | EUR 90 | buy | 37.40%Upside | Reiterated | J.P. Morgan | ||
| Axel Herlinghaus | 10/29/26 | ― | buy | ― | Reiterated | DZ BANK AG | ||
| James Edwardes Jones | 10/28/26 | EUR 78→EUR 76 | hold | 16.03%Upside | Reiterated | RBC Capital | ||
| David Hayes | 10/28/26 | EUR 60 | sell | -8.40%Downside | Reiterated | Jefferies | ||
| Guillaume Delmas | 10/28/26 | EUR 93 | buy | 41.98%Upside | Reiterated | UBS | ||
| Callum Elliott | 10/28/26 | EUR 92 | buy | 40.46%Upside | Reiterated | Bernstein | ||
| Tom Sykes | 10/05/26 | EUR 61→EUR 59 | hold | -9.92%Downside | Reiterated | Deutsche Bank | ||
| David Roux | 07/30/26 | EUR 80→EUR 83 | buy | 26.72%Upside | Reiterated | Morgan Stanley | ||
| Warren Ackerman | 07/07/26 | EUR 81→EUR 83 | buy | 26.72%Upside | Reiterated | Barclays | ||
| 06/10/26 | EUR 85 | buy | 29.77%Upside | Upgraded | Banco Santander | |||
| Jon Cox | 05/04/26 | EUR 85 | buy | 29.77%Upside | Reiterated | Kepler Capital | ||
| Matthew Abraham | 04/23/26 | EUR 83→EUR 79 | hold | 20.61%Upside | Reiterated | Berenberg Bank | ||
| Jeff Stent | 03/04/26 | EUR 83 | buy | 26.72%Upside | Upgraded | Exane BNP Paribas |
Best Analysts Covering DANONE SA
Copying Jon Cox's trades and holding each position for 3 Months would result in 65.91% of your transactions generating a profit, with an average return of +3.11% per trade.
Copying Celine Pannuti CFA's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +6.29% per trade.
Copying Celine Pannuti CFA's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +13.51% per trade.
BSN Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 3 | 7 |
| Buy | 29 | 22 | 19 | 12 | 8 |
| Hold | 2 | 1 | 1 | 2 | 3 |
| Sell | 4 | 5 | 4 | 5 | 5 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 35 | 28 | 24 | 22 | 23 |
In the current month, BSN has received 15 Buy Ratings, 3 Hold Ratings, and 5 Sell Ratings. BSN average Analyst price target in the past 3 months is 78.33.
BSN Financial Forecast
BSN Earnings Forecast
Next quarter’s earnings estimate for BSN is EUR 2.04 with a range of EUR 2.03 to EUR 2.05. The previous quarter’s EPS was EUR 1.92. BSN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year BSN has Performed in-line its overall industry.
BSN Sales Forecast
Next quarter’s sales forecast for BSN is EUR 7.13B with a range of EUR 7.11B to EUR 7.16B. The previous quarter’s sales results were EUR 13.94B. BSN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year BSN has Performed in-line its overall industry.